{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:30:14Z","timestamp":1783434614085,"version":"3.54.6"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Atherosclerosis is a hardening and narrowing of arteries causing a reduction of blood flow. It is a leading cause of death in industrialized countries as it causes heart attacks, strokes, and peripheral vascular disease. Pathogenesis of the atherosclerotic lesion (atheroma) relies on the accumulation of cholesterol-containing low-density lipoproteins (LDL) and on changes of artery endothelium that becomes adhesive for monocytes and lymphocytes. Immunomediated inflammatory response stimulated by lipoprotein oxidation, cytokine secretion and release of pro-inflammatory mediators, worsens the pathological context by amplifying tissue damage to the arterial lining and increasing flow-limiting stenosis. Formation of thrombi upon rupture of the endothelium and the fibrous cup may also occur, triggering thrombosis often threatening the patient\u2019s life. Purinergic signaling, i.e., cell responses induced by stimulation of P2 and P1 membrane receptors for the extracellular nucleotides (ATP, ADP, UTP, and UDP) and nucleosides (adenosine), has been implicated in modulating the immunological response in atherosclerotic cardiovascular disease. In this review we will describe advancements in the understanding of purinergic modulation of the two main immune cells involved in atherogenesis, i.e., monocytes\/macrophages and T lymphocytes, highlighting modulation of pro- and anti-atherosclerotic mediated responses of purinergic signaling in these cells and providing new insights to point out their potential clinical significance.<\/jats:p>","DOI":"10.3389\/fimmu.2020.617804","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T16:58:15Z","timestamp":1613667495000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis Development"],"prefix":"10.3389","volume":"11","author":[{"given":"Davide","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"la Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Celeghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Casciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(01)00238-0","article-title":"Atherosclerosis. the road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet (London England)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s27764","article-title":"The prevention and regression of atherosclerotic plaques: emerging treatments","volume":"8","author":"Kalanuria","year":"2012","journal-title":"Vasc Health Risk Manage"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3370-z","article-title":"Viral infection and atherosclerosis","volume":"37","author":"Hemmat","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.8.833","article-title":"Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis","volume":"102","author":"Mayr","year":"2000","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.312465","article-title":"Trained Innate Immunity as a Novel Mechanism Linking Infection and the Development of Atherosclerosis","volume":"122","author":"Leentjens","year":"2018","journal-title":"Circ Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03453-7","article-title":"Infection and atherosclerosis: TLR-dependent pathways","volume":"77","author":"Li","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1289-1","article-title":"Inflammation and immune system interactions in atherosclerosis","volume":"70","author":"Legein","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arcmed.2013.11.007","article-title":"Innate immune system cells in atherosclerosis","volume":"45","author":"Ch\u00e1vez-S\u00e1nchez","year":"2014","journal-title":"Arch Med Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.115.306256","article-title":"Macrophage Phenotype and Function in Different Stages of Atherosclerosis","volume":"118","author":"Tabas","year":"2016","journal-title":"Circ Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.10.034","article-title":"Macrophage polarization in atherosclerosis","volume":"501","author":"Yang","year":"2020","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.109.210781","article-title":"Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis","volume":"106","author":"Paulson","year":"2010","journal-title":"Circ Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.12659\/msmbr.904014","article-title":"STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis","volume":"23","author":"Gong","year":"2017","journal-title":"Med Sci Monit Basic Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00011-005-1377-2","article-title":"Gamma interferon: a central mediator in atherosclerosis","volume":"54","author":"Leon","year":"2005","journal-title":"Inflammation Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/35003221","article-title":"Interferon-gamma elicits arteriosclerosis in the absence of leukocytes","volume":"403","author":"Tellides","year":"2000","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000245830.29764.84","article-title":"T cells in atherogenesis: for better or for worse","volume":"26","author":"Robertson","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2009.07.002","article-title":"Adaptive immunity and atherosclerosis","volume":"134","author":"Andersson","year":"2010","journal-title":"Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.116.308648","article-title":"CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis","volume":"118","author":"Li","year":"2016","journal-title":"Circ Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/JAHA.111.000125","article-title":"Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models","volume":"1","author":"Ammirati","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.9.3893","article-title":"T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein","volume":"92","author":"Stemme","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-019-4790-y","article-title":"Immunity and inflammation in atherosclerosis","volume":"44","author":"Wolf","year":"2019","journal-title":"Herz"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2004.03.001","article-title":"Co-stimulation and plaque-antigen-specific T-cell responses in atherosclerosis","volume":"14","author":"Buono","year":"2004","journal-title":"Trends Cardiovasc Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.084","article-title":"Selective EGF-Receptor Inhibition in CD4(+) T Cells Induces Anergy and Limits Atherosclerosis","volume":"71","author":"Zeboudj","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/biom9090472","article-title":"Fibroblasts and Their Pathological Functions in the Fibrosis of Aortic Valve Sclerosis and Atherosclerosis","volume":"9","author":"Singh","year":"2019","journal-title":"Biomolecules"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gistera","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-09-0706","article-title":"Inflammation in atherosclerosis: transition from theory to practice","volume":"74","author":"Libby","year":"2010","journal-title":"Circ J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2017.12.001","article-title":"Causal Effect of Lipids and Lipoproteins on Atherosclerosis: Lessons from Genomic Studies","volume":"36","author":"Ference","year":"2018","journal-title":"Cardiol Clinics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.116.301135","article-title":"Danger signaling in atherosclerosis","volume":"116","author":"Zimmer","year":"2015","journal-title":"Circ Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2704","article-title":"Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1alpha and sterile vascular inflammation in atherosclerosis","volume":"14","author":"Freigang","year":"2013","journal-title":"Nat Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv759","article-title":"Inflammatory cytokines in atherosclerosis: current therapeutic approaches","volume":"37","author":"Tousoulis","year":"2016","journal-title":"Eur Heart J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00262","article-title":"Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis","volume":"29","author":"Teixeira","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3390\/toxins12060361","article-title":"Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease","volume":"12","author":"Diaz-Ricart","year":"2020","journal-title":"Toxins (Basel)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01390","article-title":"T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities","volume":"9","author":"Casciano","year":"2018","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.572876","article-title":"The IMMENSE study: the Interplay between iMMune and ENdothelial cells in mediating cardiovascular risk in Systemic lupus Erythematosus","volume":"11","author":"Bortoluzzi","year":"2020","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol Rev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-014-9427-2","article-title":"Purinergic signalling and immune cells","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309726","article-title":"Purinergic Signaling in the Cardiovascular System","volume":"120","author":"Burnstock","year":"2017","journal-title":"Circ Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"Cekic","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine","volume":"13","author":"Antonioli","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1096\/fj.15-274563","article-title":"Purinergic signaling in scarring","volume":"30","author":"Ferrari","year":"2016","journal-title":"FASEB J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-402560","article-title":"Extracellular nucleotide and nucleoside signaling in vascular and blood disease","volume":"124","author":"Idzko","year":"2014","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2015.10.031","article-title":"Purinergic receptors as potential therapeutic targets in Alzheimer\u2019s disease","volume":"104","author":"Woods","year":"2016","journal-title":"Neuropharmacology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coph.2016.04.001","article-title":"Immunosuppressive activities of adenosine in cancer","volume":"29","author":"Allard","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11883-014-0425-1","article-title":"CD39: Interface between vascular thrombosis and inflammation","volume":"16","author":"Kanthi","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.115.303395","article-title":"Purinergic Receptors in Thrombosis and Inflammation","volume":"35","author":"Hechler","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2174\/1568026043451014","article-title":"Introduction: P2 receptors","volume":"4","author":"Burnstock","year":"2004","journal-title":"Curr Top Med Chem"},{"key":"B50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/5584_2017_55","article-title":"P2X Receptor Activation","volume":"1051","author":"Kawate","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00265","article-title":"New Insights Into Permeation of Large Cations Through ATP-Gated P2X Receptors","volume":"11","author":"Peverini","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.148940","article-title":"Lipid raft association and cholesterol sensitivity of P2X1-4 receptors for ATP: chimeras and point mutants identify intracellular amino-terminal residues involved in lipid regulation of P2X1 receptors","volume":"285","author":"Allsopp","year":"2010","journal-title":"J Biol Chem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/bs.ctm.2017.05.004","article-title":"Regulation of P2X Purinergic Receptor Signaling by Cholesterol","volume":"80","author":"Murrell-Lagnado","year":"2017","journal-title":"Curr Top Membr"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M504256200","article-title":"Disruption of lipid rafts inhibits P2X1 receptor-mediated currents and arterial vasoconstriction","volume":"280","author":"Vial","year":"2005","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2174\/0929867321666141215094050","article-title":"P2X receptors in the cardiovascular system and their potential as therapeutic targets in disease","volume":"22","author":"Ralevic","year":"2015","journal-title":"Curr Med Chem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2019.09.017","article-title":"Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization","volume":"179","author":"Mccarthy","year":"2019","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00199","article-title":"P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance","volume":"11","author":"Coccurello","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01179","article-title":"The P2X7 Receptor as Regulator of T Cell Development and Function","volume":"11","author":"Grassi","year":"2020","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000003446","article-title":"Adenosine Triphosphate Release is Required for Toll-Like Receptor-Induced Monocyte\/Macrophage Activation, Inflammasome Signaling, Interleukin-1\u03b2 Production, and the Host Immune Response to Infection","volume":"46","author":"Lee","year":"2018","journal-title":"Crit Care Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2017.11.015","article-title":"The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release","volume":"1862","author":"Mugisho","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2014.1755","article-title":"Lipopolysaccharide\/adenosine triphosphate induces IL\u22121\u03b2 and IL-18 secretion through the NLRP3 inflammasome in RAW264.7 murine macrophage cells","volume":"34","author":"Xie","year":"2014","journal-title":"Int J Mol Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25930","article-title":"NLRP3 inflammasome: Its regulation and involvement in atherosclerosis","volume":"233","author":"Hoseini","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.118.311362","article-title":"NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.114.303585","article-title":"P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice","volume":"34","author":"Stachon","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15005","article-title":"Update of P2Y receptor pharmacology: IUPHAR Review 27","volume":"177","author":"Jacobson","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.068650","article-title":"Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog","volume":"311","author":"Chhatriwala","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physiologyonline.2001.16.1.1","article-title":"UTP as an extracellular signaling molecule","volume":"16","author":"Lazarowski","year":"2001","journal-title":"News Physiol Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvs187","article-title":"Mechanisms of ATP release and signalling in the blood vessel wall","volume":"95","author":"Lohman","year":"2012","journal-title":"Cardiovasc Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-385526-8.00008-4","article-title":"Molecular mechanisms of purine and pyrimidine nucleotide release","volume":"61","author":"Lazarowski","year":"2011","journal-title":"Adv Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/s41467-018-04602-0","article-title":"Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells","volume":"9","author":"Hitzel","year":"2018","journal-title":"Nat Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2019.04.004","article-title":"P2Y(2)R activation by ATP induces oxLDL-mediated inflammasome activation through modulation of mitochondrial damage in human endothelial cells","volume":"136","author":"Jin","year":"2019","journal-title":"Free Radical Biol Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2014.01.022","article-title":"P2Y2R activation by nucleotides released from oxLDL-treated endothelial cells (ECs) mediates the interaction between ECs and immune cells through RAGE expression and reactive oxygen species production","volume":"69","author":"Eun","year":"2014","journal-title":"Free Radical Biol Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30315-9","article-title":"Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis","volume":"395","author":"Chiarito","year":"2020","journal-title":"Lancet (London England)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1383.019","article-title":"Abdominal aortic aneurysm is a specific antigen-driven T cell disease","volume":"1085","author":"Platsoucas","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.806505","article-title":"Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells","volume":"119","author":"Lindeman","year":"2009","journal-title":"Circulation"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.002139","article-title":"Major Contribution of the P2Y1 Receptor in Purinergic Regulation of TNF\u03b1-Induced Vascular Inflammation","volume":"123","author":"Zerr","year":"2011","journal-title":"Circulation"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.788927","article-title":"Reduced Atherosclerotic Lesions in P2Y1\/Apolipoprotein E Double-Knockout Mice","volume":"118","author":"Hechler","year":"2008","journal-title":"Circulation"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.50.33702","article-title":"Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene","volume":"273","author":"Nagase","year":"1998","journal-title":"J Biol Chem"},{"key":"B82","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/atvbaha.116.308561","article-title":"Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice","volume":"37","author":"Chen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-313957","article-title":"Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation","volume":"117","author":"Riegel","year":"2011","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00101.2017","article-title":"The hypoxia-adenosine link during inflammation","volume":"123","author":"Bowser","year":"2017","journal-title":"J Appl Physiol (1985)"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00310","article-title":"Adenosine Receptor-Mediated Cardioprotection-Current Limitations and Future Directions","volume":"9","author":"Lasley","year":"2018","journal-title":"Front Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-012-9294-7","article-title":"G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions","volume":"8","author":"Jacobson","year":"2012","journal-title":"Purinergic Signal"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2013an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol Rev"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00858","article-title":"Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension","volume":"4","author":"Alencar","year":"2017","journal-title":"Front Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8879-2","article-title":"A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability","volume":"52","author":"Kim","year":"2015","journal-title":"Mol Neurobiol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1021\/nn5003375","article-title":"Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist","volume":"8","author":"Gao","year":"2014","journal-title":"ACS Nano"},{"key":"B91","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12443","article-title":"Transendothelial migration: unifying principles from the endothelial perspective","volume":"273","author":"Muller","year":"2016","journal-title":"Immunol Rev"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-214197","article-title":"Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysms","volume":"27","author":"Bhamidipati","year":"2013","journal-title":"FASEB J"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2018.51.10.098","article-title":"LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice","volume":"51","author":"Park","year":"2018","journal-title":"BMB Rep"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol Rev"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10649","article-title":"Elucidation of the thromboregulatory role of CD39\/ectoapyrase in the ischemic brain","volume":"109","author":"Pinsky","year":"2002","journal-title":"J Clin Invest"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.690180","article-title":"CD39\/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia\/reperfusion injury","volume":"116","author":"Kohler","year":"2007","journal-title":"Circulation"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz182","article-title":"Modulation of CD39 and exogenous APT102 correct immune dysfunction in experimental colitis and Crohn\u2019s disease","volume":"14","author":"Robles","year":"2019","journal-title":"J Crohns Colitis"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-385526-8.00006-0","article-title":"Interplay of hypoxia and A2B adenosine receptors in tissue protection","volume":"61","author":"Koeppen","year":"2011","journal-title":"Adv Pharmacol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2015.11.007","article-title":"Purinergic signalling in brain ischemia","volume":"104","author":"Pedata","year":"2016","journal-title":"Neuropharmacology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.03.024","article-title":"Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice","volume":"181","author":"Huttinger","year":"2012","journal-title":"Am J Pathol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/ATVBAHA.119.313002","article-title":"CD73 Promotes Age-Dependent Accretion of Atherosclerosis","volume":"40","author":"Sutton","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307374","article-title":"Role of the CD39\/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice","volume":"36","author":"Covarrubias","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M072132","article-title":"Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient mice","volume":"58","author":"De Giorgi","year":"2017","journal-title":"J Lipid Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-009-9158-y","article-title":"Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice","volume":"5","author":"Behdad","year":"2009","journal-title":"Purinergic Signal"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00497.x","article-title":"P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice","volume":"159","author":"Guns","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111385","article-title":"P2Y6 receptor potentiates pro-inflammatory responses in macrophages and exhibits differential roles in atherosclerotic lesion development","volume":"9","author":"Garcia","year":"2014","journal-title":"PloS One"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.3877","article-title":"The P2X7 receptor: a key player in IL-1 processing and release","volume":"176","author":"Ferrari","year":"2006","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201142268","article-title":"IL-18 associates to microvesicles shed from human macrophages by a LPS\/TLR-4 independent mechanism in response to P2X receptor stimulation","volume":"42","author":"Gulinelli","year":"2012","journal-title":"Eur J Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-009-9131-9","article-title":"P2X(7) receptor and macrophage function","volume":"5","author":"Wewers","year":"2009","journal-title":"Purinergic Signal"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-009-9132-8","article-title":"P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways","volume":"5","author":"Qu","year":"2009","journal-title":"Purinergic Signal"},{"key":"B111","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1172\/JCI61163","article-title":"IL-1 and atherosclerosis: a murine twist to an evolving human story","volume":"122","author":"Rader","year":"2012","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1038\/s41598-017-05137-y","article-title":"P2X7 receptor antagonism modulates IL-1beta and MMP9 in human atherosclerotic vessels","volume":"7","author":"Lombardi","year":"2017","journal-title":"Sci Rep"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2008.11.003","article-title":"Interferon gamma: a master regulator of atherosclerosis","volume":"20","author":"Mclaren","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.64.2.265","article-title":"Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes","volume":"64","author":"Humphreys","year":"1998","journal-title":"J\u00a0Leukoc Biol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-031377","article-title":"Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells","volume":"109","author":"Pizzirani","year":"2007","journal-title":"Blood"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011022","article-title":"Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis","volume":"195","author":"Gerdes","year":"2002","journal-title":"J Exp Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.10.027","article-title":"NLRP3 inflammasome pathways in atherosclerosis","volume":"267","author":"Baldrighi","year":"2017","journal-title":"Atherosclerosis"},{"key":"B119","article-title":"Losartan inhibits LPS + ATP-induced IL-1beta secretion from mouse primary macrophages by suppressing NALP3 inflammasome","volume":"69","author":"Wang","year":"2014","journal-title":"Die Pharmazie"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.117.027400","article-title":"P2X(7) Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in Mice","volume":"135","author":"Stachon","year":"2017","journal-title":"Circulation"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-12-1068","article-title":"Effect of P2Y12 inhibitors on inflammation and immunity","volume":"114","author":"Thomas","year":"2015","journal-title":"Thromb Haemost"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.239095","article-title":"Roles of purinergic receptor P2Y, G protein-coupled 12 in the development of atherosclerosis in apolipoprotein E-deficient mice","volume":"32","author":"Li","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.01.006","article-title":"Prasugrel inhibits platelet-enhanced pro-inflammatory CD4+ T cell responses in humans","volume":"239","author":"Johnston","year":"2015","journal-title":"Atherosclerosis"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-009-0073-8","article-title":"Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes","volume":"105","author":"Diehl","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2009.01.009","article-title":"Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice","volume":"77","author":"Afek","year":"2009","journal-title":"Microvasc Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052205","article-title":"Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent","volume":"203","author":"Galkina","year":"2006","journal-title":"J Exp Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.12.6436","article-title":"Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response","volume":"168","author":"Labasi","year":"2002","journal-title":"J Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<637::AID-JCP19>3.0.CO;2-3","article-title":"Extracellular ATP causes of loss of L-selectin from human lymphocytes via occupancy of P2Z purinocepters","volume":"166","author":"Jamieson","year":"1996","journal-title":"J Cell Physiol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation","volume":"92","author":"Cronstein","year":"1993","journal-title":"J Clin Invest"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.04.217","article-title":"CD39 identifies a microenvironment-specific anti-inflammatory CD8(+) T-cell population in atherosclerotic lesions","volume":"285","author":"Van Duijn","year":"2019","journal-title":"Atherosclerosis"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.304351","article-title":"Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) registry","volume":"35","author":"Chow","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0709513","article-title":"A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux","volume":"87","author":"Bingham","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900331","article-title":"Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation","volume":"183","author":"Barnholt","year":"2009","journal-title":"J Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-019-00345-5","article-title":"Adenosine and the Cardiovascular System","volume":"19","author":"Reiss","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"key":"B137","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pharmthera.2019.01.003","article-title":"The adenosine A2B G protein-coupled receptor: Recent advances and therapeutic implications","volume":"198","author":"Vecchio","year":"2019","journal-title":"Pharmacol Ther"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.119.012219","article-title":"Novel Insights Into the NLRP 3 Inflammasome in Atherosclerosis","volume":"8","author":"Jin","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.235176","article-title":"The P2Y(2) nucleotide receptor mediates tissue factor expression in human coronary artery endothelial cells","volume":"286","author":"Ding","year":"2011","journal-title":"J Biol Chem"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.12.015","article-title":"The role of P2Y(6)R in cardiovascular diseases and recent development of P2Y(6)R antagonists","volume":"25","author":"Zhou","year":"2020","journal-title":"Drug Discovery Today"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.07.047","article-title":"Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis","volume":"44","author":"Deo","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.159012","article-title":"P2Y6 receptor inhibition perturbs CCL2-evoked signalling in human monocytic and peripheral blood mononuclear cells","volume":"127","author":"Campwala","year":"2014","journal-title":"J Cell Sci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.046904","article-title":"Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells","volume":"74","author":"Bar","year":"2008","journal-title":"Mol Pharmacol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.05.053","article-title":"Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice","volume":"275","author":"Ganbaatar","year":"2018","journal-title":"Atherosclerosis"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218934","article-title":"Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel","volume":"14","author":"Halim","year":"2019","journal-title":"PloS One"},{"key":"B146","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00395-016-0589-7","article-title":"Protective and pathogenic roles of CD8(+) T cells in atherosclerosis","volume":"111","author":"Cochain","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1161\/circ.105.10.1158","article-title":"Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation","volume":"105","author":"Edfeldt","year":"2002","journal-title":"Circulation"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0198-8","article-title":"Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice","volume":"558","author":"Que","year":"2018","journal-title":"Nature"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2014.12.008","article-title":"Purinergic signaling in atherosclerosis","volume":"21","author":"Ferrari","year":"2015","journal-title":"Trends Mol Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s596","article-title":"Drug delivery and nanoparticles:applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int J Nanomed"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.617804\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T16:58:18Z","timestamp":1613667498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.617804\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":150,"alternative-id":["10.3389\/fimmu.2020.617804"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.617804","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"article-number":"617804"}}